Explorer les evidences

Palier Gold : evidences validées mécaniquement, avec leur source primaire.

3 256 evidences · page 86 / 131

34 mg/LThe level of C-reactive protein was significantly elevated in microscopically Plasmodium falciparum-positive pregnant women to 34 mg/L.

Gabonpaludismepublié 2006The American journal of tropical medicine and hygieneeurope_pmcdocument de 7 observationsDOI 10.4269/ajtmh.2006.75.798

19 casesOf 78 humans, mostly hunters who had been bitten or scratched by nonhuman primates, 19 were SFV seropositive.

Gabonsimian foamy retroviruses (SFVs)publié 2011Journal of VirologyOpenAlexdocument de 3 observations

17,2 %Au Gabon, le cancer du sein est le cancer le plus diagnostiqué, soit 17,2 % en 2022 selon Globocan.

Gaboncancer du seinobservé 2022HAL · Unilimdocument de 322 observations

0,1 %One patient (0.1%; 95% CI, 0.0%-0.2%) had acute hepatitis B among 762 HIV-1-positive adults from Gabon surveyed between 2010 and 2013.

Gabonhépatite B · VIH/sidaobservé 2010-2013publié 2016PloS onePubMeddocument de 7 observations

16,42 aORAbnormal bleeding was identified as an independent predictor of fatal outcome in severe malaria with adjusted odds ratio 16.42.

Gabonpaludismepublié 2023Malaria JournalOpenAlexdocument de 25 observationsDOI 10.1186/s12936-023-04512-7

26 %The overall prevalence of schistosomiasis among schoolchildren in Lambaréné, Gabon was 26% (159/614).

Gabonschistosomiasepublié 2020The American journal of tropical medicine and hygieneeurope_pmcdocument de 5 observations

7 patientsSeven patients had a mixed infection in the study on vulvovaginal candidiasis near Franceville, Gabon.

Gabonvulvovaginal candidiasispublié 2023Journal de mycologie medicaleeurope_pmcdocument de 3 observations

65,5 %Ascaris lumbricoides prevalence was 65.5% in areas hypoendemic for onchocerciasis in Gabon between January and February 2020.

Gabononchocercoseobservé January and February 2020publié 2024Pathogens (Basel, Switzerland)europe_pmcdocument de 7 observations

2,3 %Based on microscopy, the prevalence of P. malariae mono-infection was 2.3% in the OKT health district.

Gabonpaludismeobservé 2019publié 2022Parasitology researcheurope_pmcdocument de 2 observationsDOI 10.1007/s00436-021-07398-z

98 %Schistosoma haematobium egg excretion rates showed a median reduction of 98% in the mefloquine group.

Gabonschistosomiasepublié 2013Clinical infectious diseases : an official publication of the Infectious Diseases Society europe_pmcdocument de 4 observationsDOI 10.1093/cid/cis976

75 %Viral load suppression was achieved by 75% of people living with HIV receiving antiretroviral therapy in Bunia.

GabonVIH/sidapublié 2026Diseases (Basel, Switzerland)PubMeddocument de 5 observations

9 daysTerminal HRP2 half-life was estimated to be 9 days after parasite clearance using a pharmacokinetic two-compartmental elimination model.

Gabonpaludismepublié 2024Microbiology spectrumPubMed

10,7 %Among 84 HPV genotypes identified, HPV-BR accounted for 10.7% (9/84).

GabonHPV-BRobservé 2010publié 2011Journal de gynecologie, obstetrique et biologie de la reproductioneurope_pmcdocument de 12 observations

80 %Symptomatic headache accounted for 80.0% of cases.

Gabonheadacheobservé 2013 to 2014publié 2018International Journal Of Medical Science And Clinical InventionOpenAlexdocument de 14 observationsDOI 10.18535/ijmsci/v5i4.11

46,1 yearsPatients with severe COVID-19 symptoms had a mean age of 46.1 years (SD 14.7 years), compared to 41.3 years (SD 12.5 years) for those with mild symptoms and 35.7 years (SD 11.3 years) for those with no symptoms.

GabonCOVID-19observé March to June 2020publié 2021JAMA network openPubMeddocument de 10 observations

0,9 %The V504A mutation in the pfkelch13 gene was found in 0.9% of isolates from febrile pediatric patients in South Gabon.

Gabonpaludismepublié 2018Infection and drug resistancePubMeddocument de 5 observations

100 %Five of the five nonimmune European controls with normal hemoglobin who developed parasitemia also developed malaria symptoms.

Gabonpaludismepublié 2018The American journal of tropical medicine and hygieneeurope_pmcdocument de 12 observations

The rate of malaria infection was significantly higher in children aged 0 to 4 years than in children aged 5 years and above and in adults in Makokou, North Eastern Gabon.

Gabonpaludismeobservé 2006–2013publié 2015BMC Public HealthOpenAlexdocument de 3 observationsDOI 10.1186/s12889-015-1456-4

759 parasites/μLLa densité médiane de parasites Plasmodium malariae était de 759 parasites/μL chez les enfants porteurs de l’allèle APOE Ɛ4, contre 180 parasites/μL chez les enfants non-porteurs.

GabonpaludismeHAL · Unilimdocument de 81 observations

A resurgence in maternal malaria incidence was not estimated in Lambaréné, Gabon, based on observational data from two tertiary referral hospitals spanning 2018 to early 2023.

Gabonmaternal malariaobservé 2018 to early 2023publié 2025International journal of epidemiologyeurope_pmcdocument de 5 observations

0,319 correlation_coefficientLoa loa microfilaria intensity correlated positively with Loa loa microfilaria prevalence above 30 000 mf/ml (r = 0.319, p = 0.002).

GabonLoa loa microfilariapublié 2011PLoS neglected tropical diseasesOpenAlexdocument de 7 observationsDOI 10.1371/journal.pntd.0001329

2,2 %2.2% of hepatitis C virus strains identified in Gabon were genotype 2.

Gabonhépatite Cpublié 2012PLoS ONEOpenAlexdocument de 7 observationsDOI 10.1371/journal.pone.0042002

22,22 %The malaria positivity rate among the 367 enrolled children was 22.22%.

Gabonpaludismepublié 2023Diagnostics (Basel, Switzerland)europe_pmcdocument de 4 observationsDOI 10.3390/diagnostics13203271

32,9 %32.9% of children under 15 years of age in Libreville received their 3 doses of hepatitis B vaccine on time according to the original vaccination schedule.

Gabonhépatite Bpublié 2022Open Journal of PediatricsOpenAlexdocument de 2 observationsDOI 10.4236/ojped.2022.121022

34,1 %Vulvovaginal candidiasis (VVC) prevalence was 34.1% among 573 women of reproductive age in south-eastern Gabon.

Gabonvulvovaginal candidiasispublié 2022International journal of women's healtheurope_pmcdocument de 19 observationsDOI 10.2147/ijwh.s349754

Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.